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TABLE I-INCIDENCE OF OTITIS MEDIA IN CHILDREN, FINLAND,
1977-80*
*Adapted from M&auml;kel&auml;’s paper.
tCases per 100 children.
suggested by similar results in a previous trial of peumococcal
vaccine.’ In that trial, pneumonia and bacteraemia caused by vac-
cine types was significantly less common in vaccinees than in con-
trols (table 11), but so were pneumonia and bacteraemia caused by
TABLE II-PNEUMONIA OR BACTERAEMIA IN ELDERLY PATIENTS,
NEW YORK, 1937-43*
*Adapted from Kaufman. 
1
tCalculated by chi-square. *Calculated by Fisher’s exact test, two-tailed.
non-vaccine types and pneumonia not thought to be caused by
pneumococcus. Although not explicable on present knowledge, ad-
ministration of pneumococcal vaccine may, under some cir-
cumstances, have a protective effect that extends beyond disease
caused by vaccine types.
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DEXAMETHASONE SUPPRESSION TEST IN
DEPRESSION
SIR,-Dr Holsboer and colleagues (Sept. 27, p. 706) have had less
encouraging experience than others with the dexamethasone sup-
pression test (DST) in the diagnosis of depression. The DST results
were only moderately consistent with clinical diagnostic
assessments and an abnormal DST had a predictive value of 70% for
the diagnosis of endogenous depression. In nine other studies from
eight centres on a total of 1021 patients a much better diagnostic
performance of the DST has been recorded.2 Abnormal DST
results were found in 47% of 514 patients with endogenous or
primary depression (sensitivity), whereas 97% of 507 patients with
other psychiatric diagnoses had normal DST -results (specificity).
Thus the diagnostic confidence or predictive value of an abnormal
DST result for endogenous depression would be 93%. A standard-
1. Kaufman P. Pneumonia in old age: Active immunization against pneumonia with
pneumococcus polysaccharide: Results of a six-year study. Arch Intern Med 1947;
79: 518-31.
2. Carroll BJ: The dexamethasone suppression test for melancholia. Br J Psychiat (in
press).
ised DST has now been developed3 which gives improved sen-
sitivity (67%) while retaining a high specificity (96%).
The more important lesson from Holsboer’s report is that, as your
editorial (Oct. 4, p. 730) put it, "traditional (clinical) skills have their
limitations" so that an objective measure like the DST may help us
to identify discrepancies in diagnostic practice between different
centres. If different investigators find widely differing frequencies
of abnormal DST results among their patients, even though they
may believe they are using identical criteria for their diagnoses, then
they indeed are not studying comparable groups of patients. Similar-
ly, if some investigators begin to find a high frequency of abnormal
DST results among depressed patients whom they regard as non-
endogenous, then this may serve as a signal that their diagnostic
practice differs from that of most other workers.
As more groups begin to use the DST we may expect that a con-
sensus about its diagnostic value in psychiatry will emerge. All we
can say for the present is that we are moving towards a redefinition
of "endogenous depression". This redefinition will aim to include
the new biological markers and to give them diagnostic weightings
along with the traditional clinical features. This process is exactly
analogous to that by which specific disease concepts have developed
in other areas of medicine. We now have biological evidence to sup-
port the isolation of endogenous depression as a separate disorder
apart from the undifferentiated, heterogeneous group of conditions
termed major depressive disorder.
The DST and other objective tests4 may become particularly
useful for the asessment of patients with non-classical variants ofen-
dogenous depression such as young children, adolescents, elderly
patients with pseudodementia, catatonic depressives, schizoaffec-
tive depressives, and patients with confusing clinical features such
as a superimposed severe character disorder. some instructive sur-
prises may be in store for clinicians as they begin to match their
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LITHIUM CARBONATE IN HAEMATOLOGY
SiR,-Dr Bandini and colleagues (Oct. 25, p. 926) suggest that
lithium carbonate is of value in limiting the severity and duration of
neutropenia during remission induction therapy in adult acute lym-
phoblastic leukaemia. This may well be so but I feel it begs the ques-
tion. Neutropenia in leukaemia induction therapy is primarily of
importance because of susceptibility to infection. Whilst lithium
may reduce the severity and duration of neutropenia, its ability to
reduce the incidence of infection in remission induction has yet to
be proved. In a report of the use of lithium therapy in the treatment
of acute myelogenous leukaemia, the duration and severity of
neutropenia was significantly reduced in the lithium-treated group
compared with controls, but the incidence of infection was not.5 In-
deed, lithium may inhibit the functional integrity of granulocytes in
vitro. Bandini did not mention infective episodes. The value of
raising the neutrophil count whilst inhibiting phagocytic function
has to be carefully considered. Until controlled prospective trials
have been done, the role of lithium therapy in leukaemia remission
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